Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry L Timme

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.
Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.
Cancer Gene Therapy|March 27, 2004
Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer modelTakashi Saika, Takefumi Satoh, Nobuyuki Kusaka, et al.
Cancer|February 25, 2003
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patientsTakefumi Satoh, Guang Yang, Shin Egawa, et al.
Human Gene Therapy|March 5, 2003
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancerTakefumi Satoh, Terry L Timme, Takashi Saika, et al.
Molecular and Cellular Biology|April 25, 2002
mRTVP-1, a novel p53 target gene with proapoptotic activitiesChengzhen Ren, Likun Li, Alexei A Goltsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancerSalahaldin A Tahir, Chengzhen Ren, Terry L Timme, et al.
Experimental and Molecular Pathology|March 25, 2008
Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiationGuang Yang, Terry L Timme, Koji Naruishi, et al.
Cancer Research|February 12, 2004
RTVP-1, a tumor suppressor inactivated by methylation in prostate cancerChengzhen Ren, Likun Li, Guang Yang, et al.
Cancer Research|November 25, 2003
Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer modelTakefumi Satoh, Takashi Saika, Shin Ebara, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|July 13, 2002
Gene therapy for prostate cancerYehoshua Gdor, Terry L Timme, Brian J Miles, et al.
Cancer|February 16, 2005
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progressionGuang Yang, Terry L Timme, Anna Frolov, et al.
Cancer Gene Therapy|March 27, 2004
Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer modelTakashi Saika, Takefumi Satoh, Nobuyuki Kusaka, et al.
Cancer|February 25, 2003
Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patientsTakefumi Satoh, Guang Yang, Shin Egawa, et al.
Human Gene Therapy|March 5, 2003
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancerTakefumi Satoh, Terry L Timme, Takashi Saika, et al.
Molecular and Cellular Biology|April 25, 2002
mRTVP-1, a novel p53 target gene with proapoptotic activitiesChengzhen Ren, Likun Li, Alexei A Goltsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancerSalahaldin A Tahir, Chengzhen Ren, Terry L Timme, et al.
Experimental and Molecular Pathology|March 25, 2008
Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiationGuang Yang, Terry L Timme, Koji Naruishi, et al.
Cancer Research|February 12, 2004
RTVP-1, a tumor suppressor inactivated by methylation in prostate cancerChengzhen Ren, Likun Li, Guang Yang, et al.
Cancer Research|November 25, 2003
Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer modelTakefumi Satoh, Takashi Saika, Shin Ebara, et al.
Pageof 2